Toll Free: 1-888-928-9744

Richter Gedeon Nyrt. - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Richter Gedeon Nyrt. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Richter Gedeon Nyrt. - Product Pipeline Review - 2014', provides an overview of the Richter Gedeon Nyrt.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Richter Gedeon Nyrt.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Richter Gedeon Nyrt. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Richter Gedeon Nyrt.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Richter Gedeon Nyrt.'s pipeline products

Reasons to buy

- Evaluate Richter Gedeon Nyrt.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Richter Gedeon Nyrt. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Richter Gedeon Nyrt.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Richter Gedeon Nyrt. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Richter Gedeon Nyrt.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Richter Gedeon Nyrt. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Richter Gedeon Nyrt. Snapshot 5
Richter Gedeon Nyrt. Overview 5
Key Information 5
Key Facts 5
Richter Gedeon Nyrt. - Research and Development Overview 6
Key Therapeutic Areas 6
Richter Gedeon Nyrt. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Richter Gedeon Nyrt. - Pipeline Products Glance 11
Richter Gedeon Nyrt. - Late Stage Pipeline Products 11
Filing rejected/Withdrawn Products/Combination Treatment Modalities 11
Phase III Products/Combination Treatment Modalities 12
Richter Gedeon Nyrt. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Richter Gedeon Nyrt. - Early Stage Pipeline Products 15
Discovery Products/Combination Treatment Modalities 15
Richter Gedeon Nyrt. - Drug Profiles 16
cariprazine 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
pegfilgrastim 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
RGH-618 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
rituximab biosimilar 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
trastuzumab biosimilar 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Richter Gedeon Nyrt. - Pipeline Analysis 23
Richter Gedeon Nyrt. - Pipeline Products by Target 23
Richter Gedeon Nyrt. - Pipeline Products by Route of Administration 25
Richter Gedeon Nyrt. - Pipeline Products by Molecule Type 26
Richter Gedeon Nyrt. - Pipeline Products by Mechanism of Action 27
Richter Gedeon Nyrt. - Recent Pipeline Updates 29
Richter Gedeon Nyrt. - Dormant Projects 32
Richter Gedeon Nyrt. - Discontinued Pipeline Products 33
Discontinued Pipeline Product Profiles 33
radiprodil 33
RGH-512 33
Richter Gedeon Nyrt. - Company Statement 34
Richter Gedeon Nyrt. - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 39
Disclaimer 39
List of Tables
Richter Gedeon Nyrt., Key Information 5
Richter Gedeon Nyrt., Key Facts 5
Richter Gedeon Nyrt. - Pipeline by Indication, 2014 8
Richter Gedeon Nyrt. - Pipeline by Stage of Development, 2014 9
Richter Gedeon Nyrt. - Monotherapy Products in Pipeline, 2014 10
Richter Gedeon Nyrt. - Filing rejected/Withdrawn, 2014 11
Richter Gedeon Nyrt. - Phase III, 2014 12
Richter Gedeon Nyrt. - Phase II, 2014 13
Richter Gedeon Nyrt. - Phase I, 2014 14
Richter Gedeon Nyrt. - Discovery, 2014 15
Richter Gedeon Nyrt. - Pipeline by Target, 2014 24
Richter Gedeon Nyrt. - Pipeline by Route of Administration, 2014 25
Richter Gedeon Nyrt. - Pipeline by Molecule Type, 2014 26
Richter Gedeon Nyrt. - Pipeline Products by Mechanism of Action, 2014 28
Richter Gedeon Nyrt. - Recent Pipeline Updates, 2014 29
Richter Gedeon Nyrt. - Dormant Developmental Projects,2014 32
Richter Gedeon Nyrt. - Discontinued Pipeline Products, 2014 33
Richter Gedeon Nyrt., Other Locations 35
Richter Gedeon Nyrt., Subsidiaries 36 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify